91ÑÇÉ«´«Ã½

News

The top scientific breakthrough for 2020

David Pride
By David Pride
Dec. 27, 2020

SARS-CoV-2, the virus that causes the respiratory illness COVID-19, of those worldwide who are known to have contracted it. But the situation could be a lot worse without modern medicine and science.

The last such global scourge was the influenza pandemic of 1918, which is estimated to have at a time when there was no internet or easy access to long-distance telephones to disseminate information. Science was limited, which made it difficult to identify the cause and initiate vaccine development. The world is 100% more prepared for the current pandemic than it was 100 years ago. However, it has still affected our lives profoundly.

who specializes in the study of viruses and runs a microbiology laboratory that tests for SARS-CoV-2 infections. I've seen firsthand patients with severe COVID-19 illness and have dedicated myself to developing diagnostics for this disease. It's a remarkable testament to science that a novel disease-causing virus has been discovered, the genetic material completely decoded, new therapies created to fight it and multiple safe and effective vaccines developed all within the span of a year – an accomplishment that the journal .

Most vaccines . Until now the , which took four years. Now, in the midst of the SARS-CoV-2 pandemic, , with a second close behind. Other vaccines have already been rolled out in countries across the globe.

Science fast-tracked

This pandemic put science front and center. One of the most significant scientific advances in the past 15 years has been the ability to . The process of sequencing the genome of a virus is called , and it has revolutionized science by allowing researchers to rapidly decode the genome of a virus or bacterium, quickly and cost-effectively. This strategy was used to before epidemiologists even recognized that it had already spread around the world. Obtaining the sequence allowed for the and to figure out who was infected and how the virus might spread.

was responsible for an but was not particularly contagious and was limited mostly to Southeast Asia.

SARS-CoV-2 has evolved two separate qualities that allow it to spread more easily. First, it has an enormous potential for , in which the virus infects carriers who don't experience symptoms and may never know they are infected and transmitting the virus to others.

Second, it can spread via aerosolized particles. Most of these , which are visible and fall out of the air within three to six feet. But SARS-CoV-2 can also that remain in the air for several hours.

While in 1918 people went on , this time around, science provided us with concrete answers. There have been demonstrating the efficacy of masking. These types of studies inform the public that decrease circulating virus and thus reduce hospitalizations and death. While they don't get much fanfare, these studies are among the most important discoveries in response to this pandemic.

Masks-890x593.jpg
Masks work for cutting transmission of the coronavirus.

Science aids diagnostics

, which is short for polymerase chain reaction. This method uses specialized proteins and virus-matching DNA sequences called primers to create more copies of the virus. These additional copies allow PCR machines to detect the presence of the virus; doctors can then tell you if you are infected. Because of the availability of the virus's genome sequence, any researcher can design primers that match the virus to develop a diagnostic test.

to detect the virus and to researchers and physicians around the globe.

This was a remarkable achievement that allowed countries across the world to rapidly develop diagnostic tests using this template. This distribution changed the course of the pandemic in many countries.

Treatments have lowered mortality rates

Treatments for infectious diseases often evolve over time. There is , but over recent years treatments have evolved from those that make you very ill to those that are highly efficacious with few side effects.

We are now seeing similar things in the SARS-CoV-2 pandemic, just on an accelerated timeline. With the aid of clinical studies, we now have treatments such as , and . Physicians also know how to in ways that increase the chance of survival.

Vaccine development could end pandemic

This pandemic could end if the virus swept through the population killing millions but leaving the survivors with natural immunity. More likely the virus will snuff itself out when most of the population has been vaccinated with a SARS-CoV-2 vaccine. That is especially true in parts of the world where frequent testing and public health strategies are difficult to implement.

It took , with the first available in 1942. Other successes with and , and more recent ones like and , have provided blueprints for vaccine development.

Governments across the world have . This has led to multiple different companies developing their own different versions of vaccines. Normally, these take years to develop; however, by leveraging recent successes and accumulated knowledge, the . Normally, new vaccines go through phase 1 (safety), phase 2 (efficacy) and phase 3 (comparison) trials, but as , phases 2 and 3 can be combined for expediency. And large-scale manufacturing can begin when the vaccine is still in trials, potentially cutting years off the timeline.

Vaccine-445x297.jpg

Technology is at the forefront of the development of these vaccines. Some of the coronavirus , which essentially programs our cells to develop immune responses against SARS-CoV-2.

for SARS-CoV-2 proteins to which your body develops an immune response. Both types have thus far been shown to be effective, but long-term safety will remain controversial when vaccines are developed on such an expedited timeline.

Lessons learned

This disease, which began in Wuhan, Hubei Province, China, and was first is the perfect illustration of just how rapidly viruses spread in a connected world. We got previews of what could happen from the but the spread of SARS-CoV-2 has been on a different level. It has underscored that when we receive warnings about contagious viruses, rapid and decisive action must be taken in all parts of the world to reduce its spread.

Where there is , there have been profound reductions in virus transmission.

While the research that has made all this possible might fly under the radar right now, history will record this time as one of the greatest periods for scientific advancements.

The Conversation

This article is republished from under a Creative Commons license. Read the .

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
David Pride
David Pride

David Pride is an associate director of microbiology, University of California San Diego

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Meet Robert Helsley
Interview

Meet Robert Helsley

March 6, 2025

The Journal of Lipid Research junior associate editor studies chronic liver disease and was the first in his family to attend college.

From the Journals: MCP
Journal News

From the Journals: MCP

March 4, 2025

Protein acetylation helps plants adapt to light. Mapping protein locations in 3D tissues. Demystifying the glycan–protein interactome. Read about these recent papers.

Exploring life’s blueprint: Gene expression in development and evolution
In-person Conference

Exploring life’s blueprint: Gene expression in development and evolution

March 3, 2025

Meet Julia Zeitlinger and David Arnosti — two co-chairs of the 91ÑÇÉ«´«Ã½â€™s 2025 meeting on gene expression, to be held June 26-29, in Kansas City, Missouri.

From the journals: JLR
Journal News

From the journals: JLR

Feb. 27, 2025

Protein analysis of dopaminergic neurons. Predicting immunotherapy responses in lung cancer. ZASP: An efficient proteomics sample prep method. Read about papers on these topics recently published in Molecular & Cellular Proteomics.

New mass spectrometry assay speeds up UTI diagnosis
Journal News

New mass spectrometry assay speeds up UTI diagnosis

Feb. 25, 2025

Scientists in Quebec use liquid chromatography–mass spectrometry to reduce the time needed to test for bacteria in urine from days to minutes — and with smaller samples.

From the journals: MCP
Journal News

From the journals: MCP

Feb. 21, 2025

Protein analysis of dopaminergic neurons. Predicting immunotherapy responses in lung cancer. ZASP: An efficient proteomics sample prep method. Read about papers on these topics recently published in Molecular & Cellular Proteomics.